Author profile: Argüelles Arias, Federico
Institutional data
| Name | Argüelles Arias, Federico |
| Department | Medicina |
| Knowledge area | Medicina |
| Professional category | Profesor Contratado Doctor (Plaza Vinc.) |
| Request | |
 |
|
Statistics
-
No. publications
53
-
No. visits
5198
-
No. downloads
9364
| Publications |
|---|
PhD Thesis
 ¿Influye el genotipo HLA-DQA1*05 en la respuesta frente a los fármacos anti-TNF y nuevos biológicos ustekinumab y vedolizumab?
(2024)
El éxito de las estrategias con fármacos anti-TNF en el tratamiento de la enfermedad inflamatoria intestinal (EII) se ve ... |
Article
Effects of polyphenolic maqui ( Aristotelia chilensis ) extract on the inhibition of NLRP3 inflammasome and activation of mast cells in a mouse model of Crohn's disease-like colitis
(Frontiers Media S.A., 2024)
Introduction: Crohn’s disease (CD) involves activation of mast cells (MC) and NFкB in parallel with the PPAR-a/NLRP3 ... |
Article
Performance of a Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA
(Springer, 2023)
Background Therapeutic drug monitoring of infliximab levels in patients with inflammatory bowel disease (IBD) optimizes ... |
PhD Thesis
Pseudopólipos inflamatorios en pacientes con enfermedad inflamatoria intestinal: correlación entre hallazgos macroscópicos y microscópicos, clasificación histológica e implicaciones clínicas
(2023)
Los pseudopólipos inflamatorios (PPII) son lesiones no neoplásicas que aparecen como consecuencia de repetidos ciclos de ... |
PhD Thesis
Evaluación de la variabilidad interobservador de las escalas endoscópicas de actividad en pacientes con enfermedad de Crohn y su correlación con índices clínicos y biomarcadores
(2023)
Introducción: La evaluación de la actividad endoscópica en pacientes con enfermedad de Crohn (EC) es de gran relevancia ... |
Article
Clinical Utility of Urinary Gluten Immunogenic Peptides in the Follow-up of Patients with Coeliac Disease
(Wiley-Blackwell, 2023)
Background: Gluten-free diet (GFD) is the only treatment for patients with coeliac disease (CD). and its compliance should ... |
Article
Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study
(SAGE Publishing, 2023)
Background: Clinical trials have demonstrated the efficacy and safety of ustekinumab in Crohn’s disease (CD). However, ... |
Article
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing
(SAGE Publications, 2023)
Background: Ustekinumab (UST) is indicated for the treatment of Crohn's disease (CD) and Ulcerative Colitis (UC). Despite ... |
Article
Effectiveness and safety of ustekinumab dose escalation in Crohn’s disease: a multicenter observational study
(Aran Ediciones S.A., 2023)
Background: ustekinumab has proven effective in Crohn’s disease (CD). However, some patients will partially respond or ... |
Article
Safe use of proton-pump inhibitors
(Aran Ediciones S.A., 2023)
Proton-pump inhibitors (PPIs) are one of the most widely used drug classes worldwide. Their discovery goes back to the ... |
Article
The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab
(Aran Ediciones S.A., 2023)
Background: the success of strategies with earlier anti-TNF drugs for the treatment of inflammatory bowel disease (IBD) ... |
Article
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
(MDPI, 2022)
Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with ... |
Article
Long-term real-world effectiveness and safety of ustekinumab in Crohn's disease patients: the SUSTAIN study.
(Oxford University Press, 2022)
Background: Large real-world-evidence studies are required to confirm the durability of response, effectiveness, and safety ... |
Article
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
(Frontiers Media S.A., 2022)
Background: Previous studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and ... |
Article
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
(MDPI, 2022)
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for ... |
Article
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: results from the VERNE study
(Elsevier, 2022)
Background Anti-TNFα represent one of the main treatment approaches for the management of inflammatory bowel diseases ... |
Article
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
(MDPI, 2022)
Ustekinumab has shown efficacy in Crohn’s Disease (CD) patients. To identify patient profiles of those who benefit the ... |
Article
Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
(Sage Publishing, 2022)
Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD) and can result in ... |
Article
Ustekinumab in Crohn’s disease: real-world outcomes and predictors of response
(Aran Ediciones S.A., 2022)
Background: ustekinumab is a monoclonal antibody that inhibits interleukins IL-12 and IL-23, and is approved for the ... |
Article
Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori
(Aran Ediciones S.A., 2022)
Introduction: the primary goal of this study was to com pare gastrointestinal symptom reduction in patients on bismuth-containing ... |
Article
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
(Aran Ediciones S.A., 2022)
Background: tofacitinib is a Janus kinase inhibitor approved for the treatment of moderate-severe ulcerative colitis (UC). ... |
Article
Native Chilean Berries Preservation and In Vitro Studies of a Polyphenol Highly Antioxidant Extract from Maqui as a Potential Agent against Inflammatory Diseases
(MDPI, 2021)
The best conservation method for native Chilean berries has been investigated in combination with an implemented large-scale ... |
PhD Thesis
Monitorización de niveles de Infliximab y anticuerpos Anti-Infliximab en pacientes con enfermedad inflamatoria intestinal en práctica clínica
(2021)
Introducción Infliximab (IFX) es un fármaco anti-TNF que consigue una buena tasa de respuesta y remisión en muchos pacientes ... |
Article
Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
(SAGE Publishing, 2021)
Background: Irritable bowel syndrome with diarrhoea (IBS-D) is a frequent problem associated with a significant socioeconomic ... |
Article
Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
(Thieme, 2021)
Background and study aims: Endoscopy plays an essential role in managing patients with ulcerative colitis (UC), as it ... |
Article
Perspectiva de los pacientes con enfermedad inflamatoria intestinal durante la pandemia COVID-19: resultados Encuesta ACCU
(Arán Ediciones, S.L., 2021)
Introducción y objetivos: la pandemia por el SARS-CoV-2 ha obligado a un cambio sustancial en la atención a los pacien- tes ... |
PhD Thesis
Evaluación de la variabilidad interobservador de los scores endoscópicos que valoran la actividad de la enfermedad en pacientes con colitis ulcerosa
(2020)
Objetivos: el objetivo principal del estudio fue evaluar la variabilidad interobservador para el Índice de Mayo Endoscópico ... |
Article
Small Bowel Enteroscopy-A Joint Clinical Guideline from the Spanish and Portuguese Small Bowel Study Groups
(Karger Publishers, 2020)
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel ... |
Article
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: The VERNE study
(BMJ Publishing Group, 2020)
Objective To evaluate the impact of comorbidities and extraintestinal manifestations of inflammatory bowel disease on the ... |
Article
Polymeric nanoparticles for drug delivery: Recent developments and future prospects
(Multidisciplinary Digital Publishing Institute (MDPI), 2020)
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led to an increasing interest in the ... |
Article
Cut-off ranges of infliximab serum levels in Crohn’s disease in the clinical practice
(Aran Ediciones S.A., 2020)
Introduction: between 30 % and 40 % of patients treated with infliximab lose response during maintenance. Ther apeutic ... |
Article
Small bowel enteroscopy – A joint clinical guideline by the Spanish and Portuguese small-bowel study groups
(Aran Ediciones S.A., 2020)
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the manage ment of small-bowel ... |
Article
 Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn' s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways
(MDPI, 2020)
Nutraceuticals include a wide variety of bioactive compounds, such as polyphenols, which have been highlighted for their ... |
Article
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA study
(Aran Ediciones S.A., 2020)
Introduction: project CONDIFA (“Consenso Digestivo-Far macia Hospitalaria”) aims to establish lines of agreement between ... |
Article
Vedolizumab response in inflammatory bowel disease. Two years of follow-up
(Aran Ediciones S.A., 2020)
Background: vedolizumab is an α4β7 integrin antagonist. The aim of this study was to evaluate the clinical response and ... |
Article
Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?
(Aran Ediciones S.A., 2020)
Introduction: endoscopy plays an essential role in the management of patients with ulcerative colitis (UC), as it allows ... |
Article
National survey on the experiences of people with celiac disease in Spain. The CELIAC-SPAIN project
(Aran Ediciones S.A., 2020)
Introduction: coeliac disease (CD) is well known, but not so its impact on the patient’s life. Objective: to determine ... |
Article
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
(Original Research, 2019)
Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated ... |
PhD Thesis
Valoración de la eficacia de Infliximab biosimilar (CT-P13, remsima®) frente al Infliiximab original (Remicade®) en pacientes con enfermedad inflamatoria intestinal.
(2018)
Introducción: las terapias biológicas, particularmente agentes anti-TNF alfa, han revolucionado el enfoque terapéutico de ... |
Article
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
(Aran Ediciones S.A., 2018)
Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of ... |
Article
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
(Lippincott Williams & Wilkins, 2017)
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory ... |
Article
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
(Aran Ediciones S.A., 2017)
Objective: To evaluate the efficacy and safety of a quadruple regimen (BMTO) of the “3-in-1 capsule” (containing bismuth ... |
Article
A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopists
(Aran Ediciones S.A., 2017)
Introduction: Endoscopy plays a key role for the diagnosis and management of gastrointestinal disorders. Therefore, quality ... |
Article
Evolution of the incidence of inflammatory bowel disease in Southern Spain
(Aran Ediciones S.A., 2017)
Background: The incidence of inflammatory bowel disease is increasing in Europe and in Spain. However, there is no recent ... |
Article
Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey
(Aran Ediciones S.A., 2017)
colitis (UC) about their disease and access to a specialist are important to improve health outcomes. Our objective was ... |
PhD Thesis
Estudio comparativo, prospectivo y randomizado de tres preparaciones para el estudio del colon mediante cápsula endoscópica de colón
(2016)
Introducción y objetivos. El cáncer colorrectal (CCR) representa en conjunto el 10% de todos los tumores a nivel mundial. ... |
Article
Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva
(Aran Ediciones S.A., 2016)
Introduction: In the last few years a significant number of papers have related the use of proton-pump inhibitors (PPIs) ... |
Article
How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey
(Aran Ediciones S.A., 2016)
Introduction: Not all national health centers include special ized units or clinicians devoted to inflammatory bowel ... |
Article
Initial experience with golimumab in clinical practice for ulcerative colitis
(Aran Ediciones S.A., 2016)
Background: Golimumab is a TNF-blocking agent indicated as a second-line therapy in ulcerative colitis. Purpose: To ... |
| Article |
| Article |
| Article |
| Article |